Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

The New England Journal of Medicine
ASCEND Study Collaborative GroupJane Armitage

Abstract

Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but increases the risk of bleeding; the balance of benefits and hazards for the prevention of first cardiovascular events in patients with diabetes is unclear. We randomly assigned adults who had diabetes but no evident cardiovascular disease to receive aspirin at a dose of 100 mg daily or matching placebo. The primary efficacy outcome was the first serious vascular event (i.e., myocardial infarction, stroke or transient ischemic attack, or death from any vascular cause, excluding any confirmed intracranial hemorrhage). The primary safety outcome was the first major bleeding event (i.e., intracranial hemorrhage, sight-threatening bleeding event in the eye, gastrointestinal bleeding, or other serious bleeding). Secondary outcomes included gastrointestinal tract cancer. A total of 15,480 participants underwent randomization. During a mean follow-up of 7.4 years, serious vascular events occurred in a significantly lower percentage of participants in the aspirin group than in the placebo group (658 participants [8.5%] vs. 743 [9.6%]; rate ratio, 0.88; 95% confidence interval [CI], 0.79 to 0.97; ...Continue Reading

References

Mar 1, 1985·Progress in Cardiovascular Diseases·S YusufP Sleight
May 15, 2007·Lancet·Enrico FlossmannUNKNOWN British Doctors Aspirin Trial and the UK-TIA Aspirin Trial
Jan 17, 2008·Diabetologia·R AjjanP J Grant
Nov 11, 2008·JAMA : the Journal of the American Medical Association·Hisao OgawaUNKNOWN Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators
Mar 4, 2010·JAMA : the Journal of the American Medical Association·F Gerald R FowkesUNKNOWN Aspirin for Asymptomatic Atherosclerosis Trialists
Feb 18, 2016·Cerebrovascular Diseases·Frank G van RooijEwoud J van Dijk
Aug 29, 2017·The New England Journal of Medicine·John W EikelboomUNKNOWN COMPASS Investigators
Aug 28, 2018·The New England Journal of Medicine·UNKNOWN ASCEND Study Collaborative GroupJane Armitage
Aug 28, 2018·The New England Journal of Medicine·UNKNOWN ASCEND Study Collaborative GroupJane Armitage

❮ Previous
Next ❯

Citations

Aug 28, 2018·The New England Journal of Medicine·UNKNOWN ASCEND Study Collaborative GroupJane Armitage
Oct 18, 2018·The New England Journal of Medicine·Paul M Ridker
Nov 13, 2018·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·R A Ajjan
Nov 15, 2018·European Journal of Preventive Cardiology·Jose M MostazaJuan Cardenas
Oct 12, 2018·Drugs & Aging·Arshag D Mooradian
Nov 27, 2018·Annals of Internal Medicine·Michael Pignone, Darren A DeWalt
Oct 9, 2018·Expert Opinion on Pharmacotherapy·Beata FranczykJacek Rysz
Dec 7, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasutsugu Shiono, Takashi Akasaka
Jan 19, 2019·The Annals of Pharmacotherapy·Erin Carson, Alice N Hemenway
Jan 23, 2019·JAMA : the Journal of the American Medical Association·Sean L Zheng, Alistair J Roddick
Jan 23, 2019·JAMA : the Journal of the American Medical Association·J Michael Gaziano
Feb 1, 2019·Journal of Thrombosis and Thrombolysis·Dylan L Steen
Jan 15, 2019·Journal of Diabetes Investigation·Ying Xing, Kathryn Cb Tan
Feb 15, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Arjun Majithia, Deepak L Bhatt
Mar 18, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alexandru BurlacuAdrian Covic
Apr 4, 2019·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Christine GyldenkerneMichael Maeng
Apr 9, 2019·Journal of Internal Medicine·M LeggioA Mazza
Mar 25, 2019·The Journal of Clinical Endocrinology and Metabolism·Derek LeRoithAlan J Sinclair
Apr 20, 2019·Diabetes, Obesity & Metabolism·Satya Dash, Lawrence A Leiter
May 3, 2019·JAMA Oncology·Marko SkelinMarko Lucijanic
Apr 22, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·L VernstrømK L Funck
Mar 31, 2019·Annals of the Rheumatic Diseases·Antonis FanouriakisDimitrios T Boumpas
Jul 8, 2019·European Heart Journal·Colin Baigent, Michael V Holmes
Jul 16, 2019·Expert Review of Cardiovascular Therapy·Michael E PlazakStormi E Gale
Jul 25, 2019·Pharmacoepidemiology and Drug Safety·Aya AjroucheFlorence Tubach
Jul 25, 2019·Journal of Cardiovascular Pharmacology and Therapeutics·Aya AjroucheFlorence Tubach
Jul 18, 2019·Expert Review of Cardiovascular Therapy·Salam KhalilM Chadi Alraies
Apr 2, 2019·Journal of Thrombosis and Haemostasis : JTH·Giovanna PetrucciBianca Rocca
Jun 21, 2019·Current Opinion in Cardiology·Thomas Knickelbine, Michael D Miedema
Aug 7, 2019·European Heart Journal. Cardiovascular Pharmacotherapy·Andreas SchäferJohann Bauersachs
Jul 30, 2019·Oxidative Medicine and Cellular Longevity·Patricia MarchioMaria D Mauricio
Oct 2, 2019·International Journal of Clinical Practice·Jing LiuYong Huo
Nov 5, 2019·Annals of Internal Medicine·Sandeep Vijan
Sep 1, 2019·Current Pharmaceutical Design·Alessandra VecchiéAldo Bonaventura
Jan 3, 2019·European Heart Journal·Željko ReinerUlf Landmesser
Sep 23, 2019·Internal and Emergency Medicine·Francesca Santilli, Paola Simeone
Apr 26, 2019·Journal of Hypertension·Giovambattista Desideri, Claudio Ferri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

The New England Journal of Medicine
ASCEND Study Collaborative GroupJane Armitage
The New England Journal of Medicine
HPS3/TIMI55–REVEAL Collaborative GroupMartin J Landray
The New England Journal of Medicine
John J McNeilASPREE Investigator Group
The New England Journal of Medicine
John W EikelboomCOMPASS Investigators
The New England Journal of Medicine
JoAnn E MansonVITAL Research Group
© 2022 Meta ULC. All rights reserved